Sort   by:  
 Page size 
UnknownIntracellular secretory leukoprotease inhibitor modulates inositol 1,4,5-triphosphate generation and exerts an anti-inflammatory effect on neutrophils of individuals with cystic fibrosis and chronic obstructive pulmonary disease.
Not available
S-EPMC3773400 | biostudies-literature
UnknownA randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19.
Not available
S-EPMC8913266 | biostudies-literature
UnknownAnaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study.
Not available
S-EPMC6376871 | biostudies-literature
UnknownTriple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes.
Not available
S-EPMC8982185 | biostudies-literature
UnknownA CFTR potentiator in patients with cystic fibrosis and the G551D mutation.
Not available
S-EPMC3230303 | biostudies-literature
UnknownSafety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.
Not available
S-EPMC12815409 | biostudies-literature
UnknownExtended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study.
Not available
S-EPMC11894929 | biostudies-literature
Sort   by:  
 Page size